Using BFDP for the correction, of all the significant results we found above, only the association between TP53 IVS3 16 bp polymorphism and BC risk was observed in overall analysis (GG vs. CC: BFDP = 0.738), matched studies subgroup (GG vs. CC: BFDP = 0.173; GG vs. CC + CG: BFDP = 0.447), and tumor size below 2 cm (GG vs. CC: BFDP = 0.088; GG + CG vs. CC: BFDP = 0.730; GG vs. CC + CG: BFDP = 0.311). Here, TP53 is linked to breast cancer.